UroPartners Revenue and Competitors

USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • UroPartners's estimated annual revenue is currently $84.3M per year.(i)
  • UroPartners's estimated revenue per employee is $297,000

Employee Data

  • UroPartners has 284 Employees.(i)
  • UroPartners grew their employee count by 4% last year.

UroPartners's People

NameTitleEmail/Phone
1
Chief Radiation TherapistReveal Email/Phone
2
Chief Radiation TherapistReveal Email/Phone
3
Chief Radiation TherapistReveal Email/Phone
4
ControllerReveal Email/Phone
5
Laboratory Medical DirectorReveal Email/Phone
6
Director Clinical SrrvicesReveal Email/Phone
7
Marketing DirectorReveal Email/Phone
8
Physician, medical directorReveal Email/Phone
9
Chief Medical Information OfficerReveal Email/Phone
10
Senior Director Revenue Cycle OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$71M23920%N/AN/A
#2
$8M379%N/AN/A
#3
$177.2M525-19%N/AN/A
#4
$126.6M375-2%N/AN/A
#5
$16M6620%N/AN/A
#6
$45.7M15415%N/AN/A
#7
$116.2M33913%$117MN/A
#8
$108.4M3162%$440.7KN/A
#9
$122.5M36314%N/AN/A
#10
$50.2M16934%N/AN/A
Add Company

What Is UroPartners?

UroPartners is an extensive network of physician practices with locations throughout Chicagoland. The physicians of UroPartners are all board-certified specialists in urology whose skill and expertise combine to provide today’s most innovative treatments for urological disorders.\r\n\r\nLike us on Facebook at https://www.facebook.com/pages/UroPartners-LLC/118894771458385

keywords:N/A

N/A

Total Funding

284

Number of Employees

$84.3M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

UroPartners News

2022-03-30 - United States Clinical Laboratory Services Market Growth ...

... Cleveland Clinic (Hospital-based Laboratory); UroPartners (POL); Care Mount Medical (Physician Owned Laboratory).

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$100.9M284N/AN/A
#2
$84.3M284N/AN/A
#3
$84.3M28425%N/A
#4
$15M28410%N/A
#5
$79.3M28413%N/A